These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1002366)

  • 21. [Antihypertensive effect of nitrendipine, nifedipine and acebutolol and their combination on resting and exercise blood pressure in hypertensive patients].
    Franz IW; Wiewel D
    Z Kardiol; 1985 Feb; 74(2):111-6. PubMed ID: 3158125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hemodynamic effects of the intravenous form of acebutolol].
    Delaye J; Pourchaire J; Gonin A
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3239-43. PubMed ID: 1219631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The beta-blocking effect of diacetolol in humans and its relationship to plasma levels.
    Flouvat B; Roux A; Delhotal B; Lemaigre D; Leroy M; Liot F
    Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):358-61. PubMed ID: 6126441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectoris.
    Silke B; Nelson GI; Verma SP; Ahuja RC; Okoli RC; Hussain M; Taylor SH
    Herz; 1984 Feb; 9(1):57-64. PubMed ID: 6368345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The electrophysiological evaluation of intravenous acebutolol, a beta-blocking drug.
    Marrott PK; Ruttley MS; Jenkins PM; Muir JR
    Eur J Cardiol; 1977 Oct; 6(2):117-30. PubMed ID: 913484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acebutolol and left ventricular function: assessment by radionuclide angiography.
    Katz RJ; DiBianco R; Singh S; Bortz R; Bates HR; Sauerbrunn B; Laddu AR; Fletcher RD
    Clin Pharmacol Ther; 1981 Feb; 29(2):149-54. PubMed ID: 7460480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experimental analysis of the cardiovascular effects of acebutolol, a drug with beta-adrenolytic activity].
    Marmo E; Rossi F; Lampa E; Chieppa S; Apolito A; Del Vecchio F
    Arch Sci Med (Torino); 1978; 135(1):57-78. PubMed ID: 25058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacology of acebutolol in animals].
    Basil B
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3217-21. PubMed ID: 1219628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of buccal nitroglycerin on pulmonary artery pressure at rest and during exercise: a comparison with sublingual nitroglycerin in patients with coronary artery disease.
    Langbehn AF; Sheikhzadeh A; Stierle U; Thoran P
    Z Kardiol; 1983; 72 Suppl 3():239-45. PubMed ID: 6421010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive effects on blood pressure at rest and during exercise of calcium antagonists, beta-receptor blockers, and their combination in hypertensive patients.
    Franz IW; Wiewel D
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1037-42. PubMed ID: 6085363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
    Rousseau MF; Pouleur H; Cocco G; Wolff AA
    Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of the antihypertensive action of acebutolol at rest and during exercise. Apropos of 20 cases].
    Barraine R; Bonot G
    Ann Cardiol Angeiol (Paris); 1977; 26(4):339-43. PubMed ID: 329738
    [No Abstract]   [Full Text] [Related]  

  • 33. Onset and duration of beta-adrenergic receptor blockade following single oral dose acebutolol hydrochloride (Sectral).
    Watson RD; Littler WA
    Br J Clin Pharmacol; 1979 Jun; 7(6):557-61. PubMed ID: 37868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-response effects of cardioselective beta blockade in coronary artery disease.
    Silke B; Nelson G; Hussain M; Verma SP; Taylor SH
    Clin Pharmacol Ther; 1984 Jul; 36(1):40-6. PubMed ID: 6734047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acebultolol: basis for the prediction of effect on exercise tolerance.
    Biron P; Tremblay G
    Clin Pharmacol Ther; 1976 Mar; 19(3):333-8. PubMed ID: 4256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential antianginal responsiveness to acebutolol.
    Biron P; Tremblay G
    Eur J Clin Pharmacol; 1975; 8(1):15-9. PubMed ID: 786672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of oral acebutolol and propranolol on forearm blood flow in hypertensive patients.
    Ireland MA; Littler WA
    Br J Clin Pharmacol; 1981 Sep; 12(3):363-8. PubMed ID: 7295466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of once and twice daily administration of acebutolol in hypertension.
    Watson RD; Stallard TJ; Littler WA
    Br J Clin Pharmacol; 1980 Feb; 9(2):209-12. PubMed ID: 6766731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute hemodynamic effects and cardioselectivity of acebutolol, practolol, and propranolol.
    Wollam GL; Cody RJ; Tarazi RC; Bravo EL
    Clin Pharmacol Ther; 1979 Jun; 25(6):813-20. PubMed ID: 445948
    [No Abstract]   [Full Text] [Related]  

  • 40. Beta-blocking potency and electrophysiologic effects of acebutolol.
    Singh BN; Williams R; Harrison DC
    Am Heart J; 1985 May; 109(5 Pt 2):1126-31. PubMed ID: 2859775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.